Jeffrey W. Runge

Jeffrey W. Runge is Director at PHARMATHENE, INC (PIP). They have made 3 open-market trades across 2 companies since 2011, most recently 2021-06-01.

CIK 0001479091

Get an email the next time Jeffrey W. Runge files.Follow for free

3 open-market purchases totalling $95K since 2011, never a sale. Too few scored purchases to measure a record yet.

Current Position

Ticker	Shares	Value
PIP	197,700	$1.3M
ADTX	5,500	$51
CONM	10,000	—
Total		$1.3M

Shares reported on the most recent Form 4, priced at the 2021-06-02 close. 1 holding could not be priced and is excluded from the total.

Grade by Ticker

CADTX

awaiting returns

Get an email the next time Jeffrey W. Runge files

Free account. One email when the next filing comes in.

Follow Jeffrey W. Runge for free

Buy Track Record

Filings3

Only 3 discretionary filings — too few to score

Discretionary filings only. 10b5-1 plan trades, tax withholding and option exercises are excluded, and each column is one row per filing rather than per execution lot.

Volume by Type

MOption Exercise

$291K

4 filings

POpen-Market Purchase

$95K

3 filings

$40K

1 filings

Companies

Trade History

3 total

ADTXBUY

$21K

2021-06-017d: -2.0%

First-Time BuyerOpportunistic BuyTop Trade

Opportunistic BuyFirst-Time Buyer

Ticker	Type	Traded	Filed	Price	Value	7d Stock	30d Stock	90d Stock
ADTX	BUY	2021-06-01	2021-06-02	$2.94	$21K	-2.0%	-13.0%	-37.0%
PIP	BUY	2011-12-12	2011-12-14	$1.30	$26K	-12.4%	-1.1%	-1.1%
PIP	BUY	2011-06-17	2011-06-20	$2.69	$48K	-12.4%	-1.1%	-1.1%

Related Insiders

Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.